NDC 52959-457 - Gabazolamine-0.5
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-457
- Package NDCs from labels
- 52959-457-30
- Manufacturer
- Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabazolamine-0.5 | Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-457-30 | Gabazolamine-0.5 | 30 in 1 BOTTLE | TABLET | 30 | 0.5 mg | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gencare-Senna-S Softgel | SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG | Pioneer Life Sciences, LLC | e60b520a-8c7e-40cd-b829-e4c2d7904f61 | 2025-06-30 | Warnings | F05Q2T2JA0 |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | ATLANTIC BIOLOGICALS CORP. | 4c02fcec-6bb7-4497-96c5-0d809209dd17 | 2025-06-27 | Warnings | F05Q2T2JA0 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | Chain Drug Consortium, LLC | 550000ba-0d6d-4666-8461-f591c14478b1 | 2025-06-27 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Chain Drug Consortium, LLC | 09449649-fd57-4446-8264-6c3bdd6621d0 | 2025-06-27 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | TARGET CORPORATION | 28fce2e2-2101-df88-e063-6394a90aa3de | 2025-06-25 | Warnings | F05Q2T2JA0 |
| Senna-S Softgel | SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG | NUVICARE LLC | 65a1cce7-984f-490a-bd68-fea97733a72f | 2025-06-24 | Warnings | F05Q2T2JA0 |
| Prolaxa | DOCUSATE SODIUM 250MG | Terrain Pharmaceuticals | 32610e42-f352-09fd-e063-6394a90abff6 | 2025-06-12 | Warnings | F05Q2T2JA0 |
| Alprazolam C-IV | ALPRAZOLAM C-IV | Direct_Rx | f6dd0e94-4a79-769f-e053-6394a90a5ae6 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| DOCUZEN | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Village Pharma | 29102014-9b0e-4899-958d-83111f94a612 | 2025-06-01 | Warnings | F05Q2T2JA0 |
| Insecticides/Pest/Food Additives Detox | BOLDO, CARDUUS MARIANUS, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Dr. Donna Restivo DC | b5778211-0e3e-44ef-bd65-a76a68cf1504 | 2025-05-23 | Warnings | OJ245FE5EU |
| Stool Softener Laxative | DOCUSATE SODIUM | Walgreens | 816c82f8-0fa5-4b22-a226-e8f22f3eaa1d | 2025-05-23 | Warnings | F05Q2T2JA0 |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Omnivium Pharmaceuticals LLC | 8fafc39b-69db-40f3-8a09-ee859e8cef19 | 2025-05-15 | Warnings, Adverse reactions | OJ245FE5EU |
| COLACE EXTRA STRENGTH STOOL SOFTNER | DOCUSATE SODIUM | Atlantis Consumer Healthcare Inc. | 34e06b05-64a5-4b3e-af38-cdcd7c1d521b | 2025-05-01 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | Belleview Bio Science | 335f41d7-5c22-7c17-e063-6294a90a8f28 | 2025-04-22 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | e5028f6d-d33d-47a9-8453-00af5cdf59a6 | 2025-04-20 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Oral Liquid | DOCUSATE SODIUM ORAL LIQUID | Kesin Pharma Corporation | 331277b8-8304-d082-e063-6394a90a4dd3 | 2025-04-18 | Warnings | F05Q2T2JA0 |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Ailex Pharmaceuticals, LLC | 329655ae-c3c0-46b2-a925-e49777f2076b | 2025-03-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Alprazolam | ALPRAZOLAM | NuCare Pharmaceuticals, Inc. | 315b5782-969a-4324-e063-6394a90acf37 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | 308047 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | NuCare Pharmaceuticals, Inc. | 315b8cf2-01a0-3f7d-e063-6394a90a39b5 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| Senna-S | SENNOSIDES AND DOCUSATE SODIUM | Meijer, Inc. | 2619be6e-877b-16a2-e063-6394a90a68da | 2025-03-24 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.